Buy MVMDF by Oct 21, 2026.

On July 23-24, an advisory committee called PCAC will vote whether to recommend that any of seven peptides be approved by the FDA for pharmaceutical compounding (see [here](https://www.fda.gov/advisory-committees/advisory-committee-calendar/july-23-24-2026-meeting-pharmacy-compounding-advisory-committee-07232026) for meeting notes). Many of those peptides, particularly BPC-157, are already used widely and available on the grey market. Were the FDA to give them the green light, companies could capitalize on those newly legal markets. Mountain Valley MD ($MVMDF, trades OTC) would be one of those companies. They have a patented …